活心方对冠心病心绞痛患者临床疗效及血清VEGF水平的影响

张超; 姚成增; 蒋梅先; 胡琪祥; 关敬树; 曹飞

doi:10.13422/j.cnki.syfjx.2014160180

您当前的位置：

首页 >

文章列表页 >

活心方对冠心病心绞痛患者临床疗效及血清VEGF水平的影响

临床 | 更新时间：2024-01-04

- 活心方对冠心病心绞痛患者临床疗效及血清VEGF水平的影响
- Effects of Huoxin Prescription on Therapeutic Efficacy of Angina Pectoris of Coronary Heart Disease and Serum Level of VEGF
- 中国实验方剂学杂志 2014年20卷第16期页码：180-183
- 作者机构：
- 作者简介：
- 基金信息：
  
  上海市卫生局基金项目（ZYSNXD-CC-HPGC-JD-003）;上海市科委基金项目（05dz19506）;上海市卫生系统优秀青年人才培养计划项目（XYQ2011064）
- DOI：10.13422/j.cnki.syfjx.2014160180
  中图分类号： R259
- 纸质出版日期：2014
- 稿件说明：
移动端阅览
张超, 姚成增, 蒋梅先, 等. 活心方对冠心病心绞痛患者临床疗效及血清VEGF水平的影响[J]. 中国实验方剂学杂志, 2014,20(16):180-183.

ZHANG Chao, YAO Cheng-zeng, JIANG Mei-xian, et al. Effects of Huoxin Prescription on Therapeutic Efficacy of Angina Pectoris of Coronary Heart Disease and Serum Level of VEGF[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 180-183.
张超, 姚成增, 蒋梅先, 等. 活心方对冠心病心绞痛患者临床疗效及血清VEGF水平的影响[J]. 中国实验方剂学杂志, 2014,20(16):180-183. DOI： 10.13422/j.cnki.syfjx.2014160180.

ZHANG Chao, YAO Cheng-zeng, JIANG Mei-xian, et al. Effects of Huoxin Prescription on Therapeutic Efficacy of Angina Pectoris of Coronary Heart Disease and Serum Level of VEGF[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 180-183. DOI： 10.13422/j.cnki.syfjx.2014160180.

摘要

目的：观察中药活心方加载治疗对冠心病心绞痛患者的临床疗效及血清血管内皮生长因子（VEGF）水平的影响。方法：将60例冠心病心绞痛患者随机分为两组，中药加载组（n=31）和对照组（n=29）；对照组采用西药常规治疗，中药加载组在西药常规治疗的基础上给予活心方加载治疗。对两组患者的中医证候疗效、心绞痛疗效、左室射血分数（LVEF）及血清VEGF水平进行观测。结果：经治疗后，与对照组相比，中药加载组患者的中医证候积分进一步降低（P<0.05），中医证候疗效和心绞痛疗效总有效率更高（P<0.05）；与治疗前相比，中药加载组患者治疗后LVEF及血清VEGF水平得以提高（P<0.05，P<0.01），而对照组无显著性变化，治疗后组间有显著差异（P<0.05）。结论：活心方加载治疗可进一步改善冠心病心绞痛患者的临床症状，提高临床疗效，并增加患者LVEF和提高其血清VEGF水平。

Abstract

Objective: To observe the effects of Huoxin prescription on therapeutic efficacy of angina pectoris of coronary heart disease and serum level of vascular endothelial growth factor(VEGF). Method: Sixty patients with angina pectoris were randomly assigned into traditional Chinese medicine(TCM) group (31 patients) and control group (29 patients). All the patients involved were treated with western medicine

and the patients in TCM group were given the Chinese medicine

Huoxin prescription

in addition. Then we observed the therapeutic efficacy of the TCM syndrome and angina pectoris

left ventricular ejection fraction (LVEF) and serum level of VEGF. Result: Compared with the control group

TCM syndrome score of the patients in TCM group was further decreased(P<0.05)

and the total efficiency of TCM syndrome and angina pectoris were higher(P<0.05). Compared with before treatment

the LVEF and serum level of VEGF of the patients in TCM group were increased(P<0.05

P<0.01)

and there were significant differences between the two groups after treatment(P<0.05). Conclusion: The symptoms of the patients in TCM group were further improved by treating with Huoxin prescription

and the therapeutic efficacy was further increased as well. Simultaneously

the LVEF and serum level of VEGF of the patients in TCM group were increased by treatment of Huoxin prescription.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

补肾调肝周期疗法及组方通过miR-140-5P/VEGF通路改善多囊卵巢综合征大鼠“着床窗口期”子宫内膜容受性机制

基于JAK2/STAT3通路介导的星形胶质细胞A1/A2表型转化探讨桃红四物汤对脑缺血再灌注损伤的保护作用

冠心静胶囊治疗气虚血瘀型冠心病心绞痛的“6+1”维度临床综合评价

小陷胸汤对5-FU介导小鼠心肌纤维化及HIF-1α/VEGF信号通路蛋白表达的影响

秦艽、威灵仙组分配伍对类风湿关节炎模型大鼠血清炎症因子及踝关节NF-κB、VEGF表达的影响